Literature DB >> 21960344

Genome-wide analysis of OCT4 binding sites in glioblastoma cancer cells.

Xue-feng Fang1, Wei-yi Zhang, Na Zhao, Wei Yu, Dong Ding, Xu Hong, Li-sha Li, Hua-rong Zhang, Shu Zheng, Biao-yang Lin.   

Abstract

OCT4, a member of the POU family of gene products, is an octamer motif-binding transcription factor. As it is known to play a crucial role in cancer processes including proliferation, invasion, and chemoradioresistance, it is important to identify the direct targets of OCT4 in living cancer cells. Here, chromatin immunoprecipitation-sequencing (ChIP-seq) was used to identify OCT4 binding sites in glioblastoma cancer cells. The results showed that 5438 OCT4 binding sites were localized in the glioblastoma cancer genome and that these sites contained a consensus sequence TTTkswTw (k=T or G, s=C or G, w=A or T), which occurred 3931 times in 2312 OCT4 binding regions. Furthermore, binding motifs of some other transcription factors were identified in OCT4 binding regions. Our results provide a valuable dataset for understanding gene regulation mechanisms underlying the function of OCT4 in glioblastoma cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21960344      PMCID: PMC3190096          DOI: 10.1631/jzus.B1100059

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  33 in total

1.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

2.  Regulation of Oct-4 gene expression during differentiation of EC cells.

Authors:  J Schoorlemmer; L Jonk; S Sanbing; A van Puijenbroek; A Feijen; W Kruijer
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

3.  Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation.

Authors:  M Pesce; X Wang; D J Wolgemuth; H Schöler
Journal:  Mech Dev       Date:  1998-02       Impact factor: 1.882

Review 4.  The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain.

Authors:  W Herr; M A Cleary
Journal:  Genes Dev       Date:  1995-07-15       Impact factor: 11.361

5.  Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells.

Authors:  H J Kraft; S Mosselman; H A Smits; P Hohenstein; E Piek; Q Chen; K Artzt; E J van Zoelen
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

6.  Solution structure of the POU-specific DNA-binding domain of Oct-1.

Authors:  N Dekker; M Cox; R Boelens; C P Verrijzer; P C van der Vliet; R Kaptein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

7.  Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.

Authors:  E Schreiber; R E Merchant; O D Wiestler; A Fontana
Journal:  Neurosurgery       Date:  1994-01       Impact factor: 4.654

8.  The DNA binding specificity of the bipartite POU domain and its subdomains.

Authors:  C P Verrijzer; M J Alkema; W W van Weperen; H C Van Leeuwen; M J Strating; P C van der Vliet
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Human embryonic genes re-expressed in cancer cells.

Authors:  M Monk; C Holding
Journal:  Oncogene       Date:  2001-12-06       Impact factor: 9.867

10.  The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis.

Authors:  Xuefeng Fang; Jae-Geun Yoon; Lisha Li; Wei Yu; Jiaofang Shao; Dasong Hua; Shu Zheng; Leroy Hood; David R Goodlett; Gregory Foltz; Biaoyang Lin
Journal:  BMC Genomics       Date:  2011-01-06       Impact factor: 3.969

View more
  6 in total

1.  OCT4 mutations in human erythroleukemic cells: implications for multiple drug resistance (MDR) phenotype.

Authors:  Bruno Rodrigues Oliveira; Marcio Azevedo Figueiredo; Gilma Santos Trindade; Luis Fernando Marins
Journal:  Mol Cell Biochem       Date:  2014-10-30       Impact factor: 3.396

2.  Expression of Oct-4 is significantly associated with the development and prognosis of colorectal cancer.

Authors:  Huan Zhou; Y U Hu; Weipeng Wang; Yong Mao; Jingjie Zhu; Bin Zhou; Jing Sun; Xueguang Zhang
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

Review 3.  The emerging roles of Oct4 in tumor-initiating cells.

Authors:  Ying-Jie Wang; Meenhard Herlyn
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-07       Impact factor: 4.249

Review 4.  Octamer-binding transcription factors: genomics and functions.

Authors:  Feng-Qi Zhao
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

5.  A novel nodal enhancer dependent on pluripotency factors and smad2/3 signaling conditions a regulatory switch during epiblast maturation.

Authors:  Costis Papanayotou; Ataaillah Benhaddou; Anne Camus; Aitana Perea-Gomez; Alice Jouneau; Valérie Mezger; Francina Langa; Sascha Ott; Délara Sabéran-Djoneidi; Jérôme Collignon
Journal:  PLoS Biol       Date:  2014-06-24       Impact factor: 8.029

6.  Expression of pluripotency-related genes in human glioblastoma.

Authors:  Álvaro Fabrício Lopes Rios; Daniela Pretti da Cunha Tirapelli; Mucio Luiz de Assis Cirino; Andressa Romualdo Rodrigues; Ester S Ramos; Carlos Gilberto Carlotti
Journal:  Neurooncol Adv       Date:  2021-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.